TabsDetailsBasic DetailsDate: Tuesday, April 14, 2015Medical Product: saxagliptin, sitagliptinHealth Outcome(s): acute myocardial infarction (AMI)heart failureMeeting Details: View the Advisory Committee Meeting Materials hereAdditional InformationRelated Assessment(s): Acute Myocardial Infarction and Heart Failure following Saxagliptin or Sitagliptin Use: A Propensity Score Matched AnalysisRelated Link(s): Anti-Diabetes Drugs and Acute Myocardial Infarction, Hospitalized Heart FailureCompleted ARIA Assessments & Impact